Dr. Al-Haddad completed his medical school followed by one year of internship in Jordan, before he moved to the U.S. to  pursue his medical residency at Cleveland Clinic in Ohio. Following his gastroenterology fellowship that included advanced endoscopy training at Mayo Clinic in Florida, Dr. Al-Haddad joined Indiana University School of Medicine in 2007 where he also pursued a Master’s degree in Clinical Research from Indiana University/ Regenstrief Health Science Institute and is currently is Professor of Medicine. During his tenure at IU, Dr. Al-Haddad served in several roles including the director of advanced endoscopy fellowship program (2007-2014), and medical director of the IU Pancreas Cyst and Pancreas Cancer Prevention Program ((2007-2014). Dr. Al-Haddad served as Associate Clinical Director in the division (2016-2019), Clinical Director (2019-2022), interim Division Director (2020-2022) before being confirmed as the Division Director in January 2023. Dr. Al-Haddad also serves as the Destination (International) services Chief, and has helped grow several new clinical programs (2016-2020) including the Medical and Endoscopic Weight Loss Program, the Advanced Practice Provider (APP) program, and the Innovative and Third Space Endoscopy programs. Dr. Al-Haddad’s clinical and research interests include pancreas disease, GI cancers and is a world-renowned expert in endosonography and in third space endoscopy who is regularly invited to present at national and international meetings. Dr. Al-Haddad mentored numerous fellows and residents, is well published with over 250 manuscripts (as of Feb 2023), and is the recipient of several research and career development grants. Dr. Al-Haddad is the current Governor of the American College of Gastroenterology for the State of Indiana, and serves as the Associate Editor for Clinical Gastroenterology and Hepatology, the American Gastroenterological Association (AGA) leading clinical journal.

Most Patients Are Willing to Undergo Elective Endoscopic Procedures During the Reopening Period of the COVID-19 Pandemic.

Rex DK, Vemulapalli KC, Kane MJ, McHenry L Jr, Sherman S, Al-Haddad M. Gastroenterology. 2020 May 16. doi: 10.1053/j.gastro.2020.05.039

Endoscopy staff are concerned about acquiring COVID-19 infection when resuming elective endoscopy.

Rex DK, Vemulapalli KC, Lahr RE, McHenry L, Sherman S, Al-Haddad M. Gastroenterology. 2020 May 16. doi: 10.1053/j.gastro.2020.05.038.

A Comparative Study of 22G versus 19G Needles for EUS-Guided Biopsies for Parenchymal Liver Disease: Are Thinner Needles Better?

Patel HK, Saxena R, Rush N, Patel SK, Dasari CS, Mneimneh W, Quickery A, Rahal MA, Temnykh L, DeWitt J, Al-Haddad M. Dig Dis Sci. 2020

ASGE guideline on minimum staffing requirements for the performance of GI endoscopy.

Jamil LH, Naveed M, Agrawal D, Fujii-Lau LL, Al-Haddad M, Buxbaum JL, Fishman DS, Jue TL, Law JK, Lee JK, Qumseya BJ, Sawhney MS, Thosani N, Storm AC, Calderwood AH, Gurudu SR, Khashab MA, Yang J, Wani SB. Gastrointest Endosc. 2020 Apr;91(4):723-729.e17

Management of Incidental Pancreatic Cystic Lesions: Integrating Novel Diagnostic and Prognostic Factors With Current Clinical Guidelines.

Kim M, Karadsheh Z, Levy A, Al-Haddad MA. J Clin Gastroenterol. 2020 May/Jun;54(5):415-427

How Can We Optimize Tools and Techniques for Endoscopic Ultrasound-Guided Liver Biopsy?

Obaitan I, Al-Haddad MA. Clin Gastroenterol Hepatol. 2020 May;18(5):1025-1027. doi: 10.1016/j.cgh.2020.01.026. Epub 2020 Jan 24.

American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the management of acute colonic pseudo-obstruction and colonic volvulus.

Naveed M, Jamil LH, Fujii-Lau LL, Al-Haddad M, Buxbaum JL, Fishman DS, Jue TL, Law JK, Lee JK, Qumseya BJ, Sawhney MS, Thosani N, Storm AC, Calderwood AH, Khashab MA, Wani SB. Gastrointest Endosc. 2020 Feb;91(2):228-235.